In experiments on tumor-transplanted mice, Deng et al. reported that RT plus anti-PD-L1 antibody treatment had a significantly higher antitumor effect than RT alone or anti-PD-L1 antibody treatment alone [15]. This evidence concerns the gene CD274 and neoplasm.